DK1263759T3 - Azainodoler - Google Patents

Azainodoler

Info

Publication number
DK1263759T3
DK1263759T3 DK00985695.6T DK00985695T DK1263759T3 DK 1263759 T3 DK1263759 T3 DK 1263759T3 DK 00985695 T DK00985695 T DK 00985695T DK 1263759 T3 DK1263759 T3 DK 1263759T3
Authority
DK
Denmark
Prior art keywords
ny3y4
compounds
halo
heteroaryl
cyano
Prior art date
Application number
DK00985695.6T
Other languages
Danish (da)
Inventor
Paul Joseph Cox
Tahir Nadeem Majid
Justine Yeun Qua Lai
Andrew David Morley
Shelley Amendola
Stephanie Deprets
Chris Edlin
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Priority claimed from PCT/GB2000/004993 external-priority patent/WO2001047922A2/en
Application granted granted Critical
Publication of DK1263759T3 publication Critical patent/DK1263759T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

The invention is directed to compositions containing physiologically active compounds of general formula (I) wherein R1 is aryl or heteroaryl; R2 represents hydrogen, acyl, cyano, halo, lower alkenyl or lower alkyl optionally substituted by a substituent selected from cyano, heteroaryl, heterocycloalkyl, -Z1R8,-C(=O)-NY3Y4,-CO2R8,-NY3Y4,-N(R6)-C(=O)-R7, -N(R6)-C(=O)-NY3Y4,-N(R6)-C(=O)-OR7, -N(R6)-SO2-R7,-N(R6)-SO2-NY3Y4 and one or more halogen atoms; R3 represents hydrogen, aryl, cyano, halo, heteroaryl, lower alkyl, -C(=O)-OR5 or -C(=O)-NY3Y; and X1 represents N, CH, C-halo, C-CN, C-R7, C-NY3Y4, C-OH, C-Z2R7, C-C(=O)-OR5, C-C(=O)-NY3Y4, C-N(R8)-C(=O)-R7, C-SO2-NY3Y4, C-N(R8)-SO2-R7, C-alkenyl, C-alkynyl or C-NO2; and their produgs, and pharmaceutically acceptable salts and solvates of such compounds and their produgs, as well as to novel compounds within the scope of fomula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.
DK00985695.6T 1999-12-24 2000-12-27 Azainodoler DK1263759T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9930698.7A GB9930698D0 (en) 1999-12-24 1999-12-24 Chemical compounds
US21581800P 2000-07-05 2000-07-05
PCT/GB2000/004993 WO2001047922A2 (en) 1999-12-24 2000-12-27 Azaindoles

Publications (1)

Publication Number Publication Date
DK1263759T3 true DK1263759T3 (en) 2011-01-10

Family

ID=10867079

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00985695.6T DK1263759T3 (en) 1999-12-24 2000-12-27 Azainodoler
DK08162392.8T DK1990343T3 (en) 1999-12-24 2000-12-27 azaindoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08162392.8T DK1990343T3 (en) 1999-12-24 2000-12-27 azaindoles

Country Status (12)

Country Link
JP (1) JP4871474B2 (en)
AT (2) ATE552258T1 (en)
DE (1) DE60044946D1 (en)
DK (2) DK1263759T3 (en)
ES (2) ES2348861T3 (en)
GB (1) GB9930698D0 (en)
ME (1) MEP49908A (en)
PL (1) PL218884B1 (en)
PT (2) PT1990343E (en)
RS (2) RS20100123A (en)
UA (1) UA76410C2 (en)
ZA (1) ZA200204126B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422057D0 (en) * 2004-10-05 2004-11-03 Astrazeneca Ab Novel compounds
EP1962830B1 (en) * 2005-12-23 2013-03-27 GlaxoSmithKline LLC Azaindole inhibitors of aurora kinases
CL2007002617A1 (en) * 2006-09-11 2008-05-16 Sanofi Aventis COMPOUNDS DERIVED FROM PIRROLO [2,3-B] PIRAZIN-6-ILO; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT INFLAMMATION OF THE ARTICULATIONS, Rheumatoid Arthritis, TUMORS, LYMPHOMA OF THE CELLS OF THE MANTO.
JP5274805B2 (en) * 2006-09-20 2013-08-28 三菱化学株式会社 Method for producing fluorinated aromatic compound
ES2464458T3 (en) * 2008-12-05 2014-06-02 F. Hoffmann-La Roche Ag Pyrrolopyrazinyl ureas as kinase inhibitors
WO2011023696A1 (en) * 2009-08-26 2011-03-03 Nycomed Gmbh Methylpyrrolopyridinecarboxamides
US9796708B2 (en) * 2013-03-14 2017-10-24 Abbvie Inc. Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9903330A2 (en) * 1996-11-19 2000-03-28 Amgen Inc. Aryl and heteroaryl substituted fused pyrrole derivatives, as antiinflammatory agents containing the same
WO1998047899A1 (en) * 1997-04-24 1998-10-29 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
BR9812944A (en) * 1997-10-20 2000-08-08 Hoffmann La Roche Bicyclic kinase inhibitors

Also Published As

Publication number Publication date
ATE552258T1 (en) 2012-04-15
RS51303B (en) 2010-12-31
JP2003519144A (en) 2003-06-17
DE60044946D1 (en) 2010-10-21
MEP49908A (en) 2011-02-10
UA76410C2 (en) 2006-08-15
PL218884B1 (en) 2015-02-27
PT1990343E (en) 2012-05-22
GB9930698D0 (en) 2000-02-16
JP4871474B2 (en) 2012-02-08
ES2348861T3 (en) 2010-12-16
YU46202A (en) 2005-06-10
ATE480537T1 (en) 2010-09-15
PT1263759E (en) 2010-11-02
DK1990343T3 (en) 2012-07-23
ES2382759T3 (en) 2012-06-13
RS20100123A (en) 2010-12-31
ZA200204126B (en) 2003-08-25

Similar Documents

Publication Publication Date Title
AP1587A (en) Azaindoles.
TW200612920A (en) Novel imidazolidine derivatives
ES2121441T3 (en) NEW DERIVATIVES OF 3,5-DIOXO - (2H, 4H) - 1,2,4 - TRIAZINE, ITS PREPARATION AND APPLICATION AS A PHARMACY
HUP0400247A2 (en) Azaindoles, process for their preparation and pharmaceutical compositions containing them
BR0309710A (en) Thickened acid composition and uses thereof
HUP0201646A2 (en) Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them
ES2193874A1 (en) Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
HK1081194A1 (en) 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof
DK1263759T3 (en) Azainodoler
EA200500122A1 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
HUP0200121A2 (en) Calcilytic compounds, pharmaceutical compositions containing them and their use
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
SE9001269D0 (en) 2-SUBSTITUTED N, N-DITRIMETHOXYBENZOYL PIPERAZINES, AND PREPARATION PROCESS OF THE SAME AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
EA200400470A1 (en) SUBSTITUTED DERIVATIVES ALKYLAMINOPIRIDAZINONE, METHOD OF THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
EA200600022A1 (en) APPLICATION OF DERIVATIVE BICYCLO [2.2.1] HEPTANA TO PREPARE NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS
MY123373A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
DE60119383D1 (en) FARNESYL TRANSFERASE-INHIBITING 4-HETEROCYCLYLCHINOLIN AND CHINAZOLINE DERIVATIVES
BG106613A (en) Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
DE60026161D1 (en) AMIDINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
HUP0301561A2 (en) Use of triazinetrione sulfoxides for preparation of compositions for controlling coccidioses
DE69828087D1 (en) AMIN DERIVATIVES
GB0114699D0 (en) Organic compounds
TH37483B (en) 5-merokyl naphthalene derivatives
YU79401A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives